I follow quite a few small cap companies. Avita manages to keep their corporate costs low in comparison to most companies in their position. Atleast most U.S. companies. Considering they have a footprint in California, the UK, Australia, + the traveling sales reps, R&D, consultants, the FDA trail expenses and costs from recruitment centers. It is expensive. They actually have some revenue to offset this, fortunately. Most Bio's do not.
I follow quite a few small cap companies. Avita manages to keep...
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.06 |
Change
-0.160(4.97%) |
Mkt cap ! $215.7M | |||
| Open | High | Low | Value | Volume |
| $3.17 | $3.17 | $3.05 | $559.2K | 180.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 10230 | $3.06 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.07 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| AVH (ASX) Chart |